← Who reports today · Health Care
Viatris (VTRS) earnings date & Q2 2026 results
The quarter in brief
Revenue grew 4.9% y/y to $3.76B, operating margin 0.2% vs 6.5%, net loss $119M (vs net loss $4.6M a year earlier).
Key growth driver: Revenue growth of +5% y/y — the report gives no segment split, so the driver is the whole business. · by the Q2 2026 report
Total revenues
$3,757M
up 4.9% y/y
Next report
not announced yet
All figures in $M.
| Line item | Amount and change |
|---|---|
| Net sales | $3,746 · +5.0% |
| Other revenues | $10.9 · −16.8% |
| Total revenues | $3,757 · +4.9% |
| Acquired IPR&D | $5.8 · vs $0 |
| Other (income) expense, net | $50.4 · vs −$334 |
| Net (loss) earnings | $119 · ×26 |
| Cost of sales | $2,300 · +2.3% |
| Research and development | $248 · +13.5% |
| Selling, general and administrative | $1,135 · +22.2% |
| Litigation settlements and other contingencies, net | $73.2 · +53.8% |
| Interest expense | $121 · +3.5% |
| Income tax provision (benefit) | $54.8 |
Verdict: revenue grew 4.9% y/y to $3.76B, operating margin 0.2% vs 6.5%, net loss $119M (vs net loss $4.6M a year earlier).
U.S. GAAP gross margin 38.8% vs 37.2%; approximately $550 million returned to shareholders; gross leverage ratio reduced to 2.9x; 2026 guidance midpoints raised.
Source and notation
Source: Viatris press release, 8-K EX-99.1 of 08/06/2026 (SEC EDGAR). Every figure was matched against the income statement in the release; SEC XBRL for this quarter is not published yet, so the XBRL check is pending.
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
- Total revenues rose 5% to $3,756.8M: Greater China grew 21% to $713.8M and Developed Markets 4%, while Emerging Markets (-2%) and JANZ (-3%) declined.
- Gross margin was 38.8% vs 37.2% a year earlier.
- Operating income was $6.3M, a 0.2% margin vs 6.5% a year earlier.
- Diluted EPS was −$0.10 vs $0.05 a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
Who runs the company now
- Scott A. SmithChief Executive Officer [1]
- Paul CampbellInterim Chief Financial Officer, Chief Accounting Officer & Corporate Controller [2]
As of 10/20/2026, per the company’s SEC filings: signatures on the latest report and leadership-change filings.
Positions: the company’s SEC filings. Spotted an error, or is this you and you’d like it corrected or removed? Contact us
How this is compiled
Who runs the company now comes from primary sources only: for US companies, the CEO and CFO signatures on the latest SEC report, and a separate board chair from the proxy statement (DEF 14A); for Russian and Kazakh issuers, the company website and its disclosures. We recheck weekly; if a name can’t be confirmed, or a leadership-change filing came out after the report, we don’t show it until it’s reviewed. History comes from proxy statements, disclosures, Wikipedia and Wikidata; years show when a term started and ended, “since” means the person is in office now. An outcome for a previous employer is shown only when the linked document states it.
Sources · 2
- SEC EDGAR: 10-Q 2026-08-06 · SEC EDGAR · 10/20/2026
- SEC EDGAR: 10-Q 2026-08-06 · SEC EDGAR · 10/20/2026
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. · Text: Wikipedia, CC BY-SA 4.0, abridged
The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Heads-up
- a net loss in Q2 2026 ($119 · ×26)
Most likely because total revenues rose 5% to $3,756.8M: Greater China grew 21% to $713.8M and Developed Markets 4%; gross margin was 38.8% vs 37.2% a year earlier. Based on the Q2 2026 report.
The company's report ↗Company guidance
Same quarter a year ago (ended September 30, 2025): revenue $3.75B, EPS (GAAP) −$0.11
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
VTRS earnings history: past report dates
| Aug 6, 2026 Thu | 7:56 ambefore market open | Jun 30, 2026 | $3.7B+5% y/y | −$0.10 |
| May 7, 2026 Thu | 7:47 ambefore market open | Mar 31, 2026 | $3.5B+8% y/y | $0.15 |
| Feb 26, 2026 Thu | 7:52 ambefore market open | Dec 31, 2025 | ≈$3.7B+5% y/y | ≈−$0.34+21% y/y |
| Nov 6, 2025 Thu | 7:53 ambefore market open | Sep 30, 2025 | $3.7B+0% y/y | −$0.11 |
| Aug 7, 2025 Thu | 7:58 ambefore market open | Jun 30, 2025 | $3.6B−6% y/y | $0.00 |
| May 8, 2025 Thu | 7:53 ambefore market open | Mar 31, 2025 | $3.2B−11% y/y | −$2.55 |
| Feb 27, 2025 Thu | 7:38 ambefore market open | Dec 31, 2024 | ≈$3.5B−8% y/y | ≈−$0.43+32% y/y |
| Nov 7, 2024 Thu | 7:58 ambefore market open | Sep 30, 2024 | $3.7B−5% y/y | $0.08−70% y/y |
| Aug 8, 2024 Thu | 8:03 ambefore market open | Jun 30, 2024 | $3.8B−3% y/y | −$0.27 |
| May 9, 2024 Thu | 7:44 ambefore market open | Mar 31, 2024 | $3.7B−2% y/y | $0.09−53% y/y |
| Feb 28, 2024 Wed | 7:39 ambefore market open | Dec 31, 2023 | ≈$3.8B−1% y/y | ≈−$0.63 |
| Nov 7, 2023 Tue | 4:39 pmafter market close | Sep 30, 2023 | $3.9B−4% y/y | $0.27−7% y/y |
| Aug 7, 2023 Mon | 7:38 ambefore market open | Jun 30, 2023 | $3.9B−5% y/y | $0.22−15% y/y |
| May 8, 2023 Mon | 7:51 ambefore market open | Mar 31, 2023 | $3.7B−11% y/y | $0.19−42% y/y |
| Feb 27, 2023 Mon | 7:38 ambefore market open | Dec 31, 2022 | ≈$3.9B−11% y/y | ≈$0.83 |
| Nov 7, 2022 Mon | 7:41 ambefore market open | Sep 30, 2022 | $4.1B−10% y/y | $0.29+12% y/y |
| Aug 8, 2022 Mon | 8:02 ambefore market open | Jun 30, 2022 | $4.1B−10% y/y | $0.26 |
| May 9, 2022 Mon | 8:15 ambefore market open | Mar 31, 2022 | $4.2B−5% y/y | $0.33 |
| Feb 28, 2022 Mon | 8:24 ambefore market open | Dec 31, 2021 | ≈$4.3B | ≈−$0.22+86% y/y |
| Aug 9, 2021 Mon | 8:31 ambefore market open | Jun 30, 2021 | $4.6B+68% y/y | −$0.23+100% y/y |
| May 10, 2021 Mon | 7:59 ambefore market open | Mar 31, 2021 | $4.4B+69% y/y | −$0.86 |
| Feb 22, 2021 Mon | 7:10 ambefore market open | Dec 31, 2020 | — | ≈−$1.59 |
| May 29, 2020 Fri | 4:35 pmafter market close | Mar 31, 2020 | $2.6B | $0.04 |
Show all 23 reports since 2020Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Viatris: 8-year financials
| 2025 | 14,300 | −2,663 | −3,515 | 1,937 |
| 2024 | 14,739 | 10.1 | −634 | 1,977 |
| 2023 | 15,427 | 766 | 54.7 | 2,523 |
| 2022 | 16,263 | 1,615 | 2,079 | 2,593 |
| 2021 | 17,886 | −34 | −1,269 | 2,560 |
| 2020 | —* | −211 | −670 | 989 |
| 2019 | 11,501 | 716 | 16.8 | 1,591 |
| 2018 | 11,434 | 906 | 353 | 2,090 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. History starts in 2018: earlier years aren’t in the company’s SEC filings (it’s younger or was spun off). “—*” in revenue: we don’t show that year’s revenue — the annual figure is more than 2% off the sum of the quarters, or the filing tags several revenue lines and the total can’t be pinned down.
Shareholders’ equity at Jun 30, 2026: $14.3B (41% of total assets). Compare with other S&P 500 companies →
Viatris (VTRS) earnings: FAQ
When is VTRS's next earnings date?
We have not yet seen an announcement of the date from Viatris (VTRS). Based on last year's report on Nov 6, 2025, the next report is expected around Nov 5, 2026.
What time does VTRS report earnings?
Viatris usually reports before market open: its latest results release was filed with the SEC at 7:56 am ET on Aug 6, 2026.
When did VTRS last report earnings?
Viatris reported Q2 2026 results on Aug 6, 2026.
Where can I find Viatris's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to VTRS's filings; this page breaks the latest report down in a Sankey chart.
How has Viatris's revenue changed since 2018?
Per its 10-K filings, revenue grew 1.3x: $11,434M in 2018 and $14,300M in 2025. The peak was $17,886M in 2021. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
More reports: WAT · Q2 2026 · WST · Q2 2026 · ZBH · Q2 2026 · ZTS · Q2 2026 · A · Q3 FY2026 · ABBV · Q2 2026 · ABT · Q2 2026 · ALGN · Q2 2026 · AMGN · Q2 2026 · BAX · Q2 2026 · all reports